[Articles] Efficacy and safety of mitapivat in patients with sickle cell disease (RISE UP): a phase 3, double-blind, global, randomised, placebo-controlled trial
Sumber 柳叶刀 Lancet10 hari lalu
Ringkasan kandungan
Mitapivat, an oral pyruvate kinase activator, with a novel mechanism that ameliorates haemolytic anaemia, has the potential to be an effective and convenient d…
Laman ini hanya menyediakan indeks tajuk dan ringkasan, kandungan penuh dan hak cipta adalah milik pihak penerbit asal, sila klik pautan asal untuk membaca.
Pergi ke artikel asal- Saluran berkaitan
- Kesihatan
- Kawasan berkaitan
- United Kingdom
- Bahasa teks asal
- English
- Nombor entri
- health-94d31632
Comments 0 comments
No comments yet. Be the first.